α-Epoxyabiraterone acetate

An impurity of Abiraterone. Abiraterone acetate is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.
Supplier BOC Sciences
Product # B0038-007223
Pricing Inquire
Molecular Weight 407.55
Molecular Formula C26H33NO3
Feedback